Analytical Data
-
基因名
ERVFRD-1
- Application
-
别名
Endogenous retrovirus group FRD member 1;Envelope polyprotein;HERV-FRD;HERV-FRD_6p24.1 provirus ancestral Env polyprotein;SU;TM
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P60508
-
表达区间
16-350aa
-
氨基酸序列
Endogenous retrovirus group FRD member 1;Envelope polyprotein;HERV-FRD;HERV-FRD_6p24.1 provirus ancestral Env polyprotein;SU;TM
-
分子量
38.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ERVFRD-1, a recombinant protein derived from the Endogenous Retrovirus Family, has garnered significant research interest due to its potential role in understanding various biological processes and diseases. Endogenous retroviruses are remnants of ancient viral infections that have integrated into the host genome, influencing immune responses and cellular functions. Recent studies suggest that ERVFRD-1 may be involved in the regulation of gene expression, immune modulation, and may even play a role in cancer biology. Researchers are particularly intrigued by its potential applications in developing novel therapeutic strategies and biomarkers for diseases linked to immune dysfunction and viral oncogenesis. The ongoing investigation into ERVFRD-1 is aimed at deciphering its molecular mechanisms and therapeutic potentials, which could lead to advancements in clinical approaches for various pathologies. Moreover, understanding ERVFRD-1's implications could further elucidate the evolutionary dynamics of retroviral elements and their contribution to human health.
